@vaxxinity

Democratizing health by creating vaccines for chronic diseases. 💛 #DemocratizeHealth

 Everywhere
linktr.ee/vaxxinity
Joined July 2020
  • Tweets517
  • Following361
  • Followers2.4K
267Media
Vaxxinity retweeted
TIME
@TIME20 Jun 2024
The new research is early, but it's a hopeful advance for patients with the neurological condition time.com/6883054/parkinsons-…

A Potential Parkinson's Treatment Has Promising Results

The new research is early, but it's a hopeful advance for patients with the neurological condition.

time.com
3
18
3
63
103,932
Vaxxinity retweeted
BioSpace@biospace20 Jun 2024
Vaxxinity published data from an early-stage clinical trial showing that its investigative immunotherapy, UB-312, could improve movement in Parkinson’s disease and protect against pathological alpha-synuclein. #parkinsons #biospace hubs.li/Q02CGTgP0

Experimental Parkinson’s Treatment Elicits Antibodies Against Toxic Protein in Phase I

Vaxxinity published data from an early-stage clinical trial showing that its investigative immunotherapy, UB-312, could improve movement in Parkinson’s disease and protect against pathological...

biospace.com
4
9
1,567
In case you missed it... nature.com/articles/s41591-0…

Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synu...

Nature Medicine - A first-in-patient trial of UB-312, an active immunotherapeutic for Parkinson’s disease, was well tolerated and elicited antibodies that engage misfolded α-synuclein.

nature.com
2
7
1,016
We're going after the root cause of Parkinson's. time.com/6883054/parkinsons-…

A Potential Parkinson's Treatment Has Promising Results

The new research is early, but it's a hopeful advance for patients with the neurological condition.

time.com
2
6
1
13
1,321
News from @vaxxinity and @UF on a #collaboration to advance #vaccine development for #neurodegenerative diseases like #parkinsons and #alzheimers. #vaccinenation #vaccines #disease #florida vaccinenation.org/therapeuti…
1
3
10
1,494
Under the agreement, @uf scientists will conduct preclinical studies exploring effects of vaccines for neurodegenerative diseases. See more: buff.ly/42zQokj #parkinsons #parkinsonsdisease #parkinsonsresearch #parkinsonstreatment
1
3
5
1,069
Check out our executive chairman @NotLouReese on Cheddar News Friday: Vaxxinity Wants to Bring Accessible Vaccines for Chronic Illness to Market. cheddar.com/media/vaxxinity-…

Vaxxinity Wants to Bring Accessible Vaccines for Chronic Illness to Market

Co-founder and executive chairman of the board at Vaxxinity Lou Reese shares how the company is working to bring vaccines for chronic illnesses like heart disease and Parkinson’s to market with an...

cheddar.com
2
5
7
1,128
Vaxxinity Inc. will work with the University of Central Florida in Orlando to develop special new vaccines for astronauts that aim to prevent a common problem created during space exploration. Click for the details. bizjournals.com/orlando/news…

Vaxxinity, UCF to develop special new vaccines for deep-space astronauts

Here's what the goal is for the envisioned vaccines to accomplish — and why that's so important for U.S. space exploration efforts in the future, as well as how they might help patients on Earth.

bizjournals.com
5
10
1,309
Could space travel research deliver a frailty vaccine? @vaxxinity and UCF collaborate on muscle and bone wasting immunotherapies to benefit both space exploration and human longevity. @NotLouReese #longevity #space #research #vaccine longevity.technology/news/co…

Could space travel research deliver a frailty vaccine?

Vaxxinity and UCF collaborate on muscle and bone wasting immunotherapies to benefit both space exploration and human longevity.

longevity.technology
7
17
1,774
Vaxxinity retweeted
Reuters
@Reuters20 Nov 2023
Researchers return to Alzheimer's vaccines, buoyed by recent drug success reut.rs/3R3MQ5M
6
15
1
51
53,309
Our CEO, Mei Mei, has been recognized on the @PharmaVoice 100 list as an inspiring leader in the life-sciences space! pharmavoice.com/news/pharmav…
3
2
11
1,469
Join us online next Monday, 9/11 at 10am ET! You won’t want to miss the latest corporate update from our CEO. Watch live here: journey.ct.events/view/7f32a…
1
1
3
833
Looking forward to presenting in September. Our H.C. Wainwright presentation will be broadcast live to the public. Tune in! ir.vaxxinity.com/news-releas…
3
933
Vaxxinity retweeted
Maersk
@Maersk13 Jul 2023
Meet our Hidden Hero Rob Townley who work with some of our most complex and high risk projects at @Maersk👊Learn more about how Rob helps bring our #purpose to life⭐ 👉Watch the full video: youtu.be/i0KeZuW6wKw #Maersk #HiddenHero #alltheway #Career
3
1
32
3,851
Jean-Cosme Dodart (@vaxxinity) discussed recently published trial findings on a novel vaccine that targets Alzheimer's disease and triggers the production of antibodies against toxic amyloid-ß peptides. Watch here 👇 ow.ly/HBLP50PAV24

Immunization Strategy as a Potential Approach to Slowing Cognitive Decline in AD: Jean-Cosme...

The senior vice president of research at Vaxxinity discussed recently published trial findings on a novel vaccine that targets Alzheimer disease and triggers the production of antibodies against...

neurologylive.com
1
3
5
755
#ICYMI: Phase 1 trial results investigating UB-312 (@vaxxinity) revealed target engagement of aggregated alpha-synuclein in cerebrospinal fluid of patients with Parkinson disease. Read more: ow.ly/21hk50PusiP

UB-312 Displays Target Engagement of Toxic Alpha-Synuclein in Phase 1 Trial for Parkinson Disease |...

Phase 1 trial results investigating UB-312 revealed target engagement of aggregated alpha-synuclein in cerebrospinal fluid of patients with Parkinson disease, providing validation of the vaccine...

neurologylive.com
1
1
5
590
Treatment with an investigational anti-#amyloid therapeutic for adults with mild #AD was safe, efficacious and demonstrated a significant immune response up to 78 weeks, per a @Vaxxinity study published in @eBioMedicine. bit.ly/3qqCAtU
1
2
379
Thought leader @DrJeffCummings sums up our latest publication in The Lancet’s @eBioMedicine about UB-311, the active vaccine candidate targeting beta-amyloid. ir.vaxxinity.com/news-releas…
2
1
4
702
Vaxxinity - Expansively Disrupting Medicine Read more: bit.ly/3OnDFuF #ChronicDiseaseVaccines
2
4
515
Vaxxinity retweeted
ADI
@AlzDisInt5 Jul 2023
Did you miss last week's fireside chat on vaccines for #dementia? If so, you can find the inspiring & informative 30-minute conversation with ADI's @WeidnerWendy, @AC_Immune_SA's Andrea Pfeifer & Mei Mei Hu of @vaxxinity, on our YouTube channel. youtu.be/h7A93G0HVxU

ADI fireside chat: The future of vaccines for Alzheimer's and dementia

In this second fireside chat, Wendy Weidner, ADI's Head of Research...

youtube.com
5
7
832
Load more